Longer-Term Safety of Fostamatinib (R788) in Patients with Rheumatoid Arthritis-Analysis of Clinical Trial Data From up to 2 Years of Exposure. Kavanaugh, A., Weinblatt, M. E., Genovese, M. C., Musser, T. K., Grossbard, E. B., Magilavy, D. B., Hollis, S., van-Sway, E., Millson, D. WILEY-BLACKWELL. 2011: S1018–S1019

View details for Web of Science ID 000297621503174